Please assess the completion status of the following clinical trial:

Trial Title: Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platform (VIP) Vascular Closure Device

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient requires closure of femoral artery puncture resulting from arterial access procedure.~* Patient is ≥18 years of age.~* Patient is willing to provide written informed consent prior to study device use.~* Patient is willing and able to adhere to data collection and follow-up requirements.~Exclusion Criteria:~* Patient is participating in another clinical trial which has the potential to impact hemostasis.~* Patient has an active groin infection or systemic infection.~* Patient has undergone a vascular access procedure within the past 90 days.~* Patient has been previously enrolled in the study. (For patients undergoing multiple interventions within a timeframe of 90 days, only the initial procedure may constitute a study enrollment.)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Angio-Seal VIP Vascular Closure (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).